IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-155

  1. 395 Posts.
    lightbulb Created with Sketch. 48
    Correct. We have to assume that the trial is still going ahead as initially planned. And @Davisite - they have calculated the sample size based on the expected effect size for the new measure so that it has sufficient power to detect a statistically significant difference.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.